A pilot study of treatment of lentigo maligna with 5% imiquimod cream

C. J. Fleming, A. M. Bryden, A. Evans, R. S. Dawe, S. H. Ibbotson

    Research output: Contribution to journalArticle

    84 Citations (Scopus)

    Abstract

    Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.
    Original languageEnglish
    Pages (from-to)485-488
    Number of pages4
    JournalThe British journal of dermatology
    Volume151
    Issue number2
    DOIs
    Publication statusPublished - Aug 2004

    Fingerprint

    imiquimod
    Hutchinson's Melanotic Freckle
    Melanoma

    Keywords

    • Aminoquinolines
    • Hutchinson's Melanotic Freckle
    • Antineoplastic Agents
    • Humans
    • Adult
    • Treatment Outcome
    • Aged
    • Pilot Projects
    • Middle Aged
    • Skin Neoplasms
    • Administration, Topical

    Cite this

    Fleming, C. J. ; Bryden, A. M. ; Evans, A. ; Dawe, R. S. ; Ibbotson, S. H. / A pilot study of treatment of lentigo maligna with 5% imiquimod cream. In: The British journal of dermatology. 2004 ; Vol. 151, No. 2. pp. 485-488.
    @article{0936318210574f489ac7910d428cbbd5,
    title = "A pilot study of treatment of lentigo maligna with 5{\%} imiquimod cream",
    abstract = "Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.",
    keywords = "Aminoquinolines, Hutchinson's Melanotic Freckle, Antineoplastic Agents, Humans, Adult, Treatment Outcome, Aged, Pilot Projects, Middle Aged, Skin Neoplasms, Administration, Topical",
    author = "Fleming, {C. J.} and Bryden, {A. M.} and A. Evans and Dawe, {R. S.} and Ibbotson, {S. H.}",
    year = "2004",
    month = "8",
    doi = "10.1111/j.1365-2133.2004.05983.x",
    language = "English",
    volume = "151",
    pages = "485--488",
    journal = "British Journal of Dermatology",
    issn = "0007-0963",
    publisher = "Wiley",
    number = "2",

    }

    A pilot study of treatment of lentigo maligna with 5% imiquimod cream. / Fleming, C. J.; Bryden, A. M.; Evans, A.; Dawe, R. S.; Ibbotson, S. H.

    In: The British journal of dermatology, Vol. 151, No. 2, 08.2004, p. 485-488.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A pilot study of treatment of lentigo maligna with 5% imiquimod cream

    AU - Fleming, C. J.

    AU - Bryden, A. M.

    AU - Evans, A.

    AU - Dawe, R. S.

    AU - Ibbotson, S. H.

    PY - 2004/8

    Y1 - 2004/8

    N2 - Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.

    AB - Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.

    KW - Aminoquinolines

    KW - Hutchinson's Melanotic Freckle

    KW - Antineoplastic Agents

    KW - Humans

    KW - Adult

    KW - Treatment Outcome

    KW - Aged

    KW - Pilot Projects

    KW - Middle Aged

    KW - Skin Neoplasms

    KW - Administration, Topical

    U2 - 10.1111/j.1365-2133.2004.05983.x

    DO - 10.1111/j.1365-2133.2004.05983.x

    M3 - Article

    VL - 151

    SP - 485

    EP - 488

    JO - British Journal of Dermatology

    JF - British Journal of Dermatology

    SN - 0007-0963

    IS - 2

    ER -